Intermittent oral hormonal chemotherapy using estramustine phosphate and etoposide for the treatment of hormone-refractory prostate cancer

Seventeen patients were given lower dose and intermittent oral administration of estramustine phosphate (6 mg/kg/day) and etoposide (30 mg/m2/day) for 7 days. Then administration was discontinued for 7 days. This administration cycle was repeated. Therapy was continued until evidence of disease prog...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Hinyokika kiyo. Acta urologica Japonica. - 1962. - 49(2003), 12 vom: 25. Dez., Seite 709-14
1. Verfasser:	Kimura, Motohiko (VerfasserIn)
Weitere Verfasser:	Sasagawa, Toru, Tomita, Yoshihiko, Katagiri, Akiyoshi, Morishita, Hideo, Saito, Toshihiro, Tanikawa, Toshiki, Kawasaki, Takashi, Saito, Kazuhide, Nishiyama, Tsutomu, Kasahara, Takashi, Hara, Noboru, Takahashi, Kota
Format:	Aufsatz
Sprache:	Japanese
Veröffentlicht:	2003
Zugriff auf das übergeordnete Werk:	Hinyokika kiyo. Acta urologica Japonica
Schlagworte:	English Abstract Journal Article Review Antineoplastic Agents, Hormonal Antineoplastic Agents, Phytogenic Estramustine 35LT29625A Etoposide 6PLQ3CP4P3